107 related articles for article (PubMed ID: 17303011)
1. Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model.
Dai LC; Wang X; Yao X; Min LS; Ping JL; He JF
Acta Pharmacol Sin; 2007 Mar; 28(3):453-8. PubMed ID: 17303011
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor growth and metastasis with antisense oligonucleotides (Cantide) targeting hTERT in an in situ human hepatocellular carcinoma model.
Lin RX; Tuo CW; Lü QJ; Zhang W; Wang SQ
Acta Pharmacol Sin; 2005 Jun; 26(6):762-8. PubMed ID: 15916744
[TBL] [Abstract][Full Text] [Related]
3. Enhanced therapeutic effects of combined chemotherapeutic drugs and midkine antisense oligonucleotides for hepatocellular carcinoma.
Dai LC; Wang X; Yao X; Lu YL; Ping JL; He JF
World J Gastroenterol; 2007 Apr; 13(13):1989-94. PubMed ID: 17461503
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis.
Dai LC; Wang X; Yao X; Lu YL; Ping JL; He JF
World J Gastroenterol; 2007 Feb; 13(8):1208-13. PubMed ID: 17451201
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotides targeting midkine induced apoptosis and increased chemosensitivity in hepatocellular carcinoma cells.
Dai LC; Wang X; Yao X; Lu YL; Ping JL; He JF
Acta Pharmacol Sin; 2006 Dec; 27(12):1630-6. PubMed ID: 17112419
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo suppression of hepatocellular carcinoma growth by midkine-antisense oligonucleotide-loaded nanoparticles.
Dai LC; Yao X; Wang X; Niu SQ; Zhou LF; Fu FF; Yang SX; Ping JL
World J Gastroenterol; 2009 Apr; 15(16):1966-72. PubMed ID: 19399928
[TBL] [Abstract][Full Text] [Related]
7. Large scale preparation of midkine antisense oligonucleotides nanoliposomes by a cross-flow injection technique combined with ultrafiltration and high-pressure extrusion procedures.
Zhong J; Yao X; Li DL; Li LQ; Zhou LF; Huang HL; Min LS; Li J; Fu FF; Dai LC
Int J Pharm; 2013 Jan; 441(1-2):712-20. PubMed ID: 23142083
[TBL] [Abstract][Full Text] [Related]
8. Antitumor Efficacy of Huqizhengxiao (HQZX) Decoction Based on Inhibition of Telomerase Activity in Nude Mice of Hepatocarcinoma Xenograft.
Yu X; Lin XJ; Wang S; Liu X; Li W; Kou BX; Chai M; Chen D; Liu X; Wang X
Integr Cancer Ther; 2018 Dec; 17(4):1216-1224. PubMed ID: 29978739
[TBL] [Abstract][Full Text] [Related]
9. Targeted expression of BikDD combined with metronomic doxorubicin induces synergistic antitumor effect through Bax activation in hepatocellular carcinoma.
Dai HY; Chen HY; Lai WC; Hung MC; Li LY
Oncotarget; 2015 Sep; 6(27):23807-19. PubMed ID: 26247632
[TBL] [Abstract][Full Text] [Related]
10. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
Zhang G; Zeng X; Zhang R; Liu J; Zhang W; Zhao Y; Zhang X; Wu Z; Tan Y; Wu Y; Du B
Phytomedicine; 2016 Nov; 23(12):1329-1336. PubMed ID: 27765352
[TBL] [Abstract][Full Text] [Related]
11. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.
Peng R; Zhao GX; Li J; Zhang Y; Shen XZ; Wang JY; Sun JY
World J Gastroenterol; 2016 Mar; 22(12):3341-54. PubMed ID: 27022216
[TBL] [Abstract][Full Text] [Related]
12. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
13. A promoter region of the midkine gene that is frequently expressed in human hepatocellular carcinoma can activate a suicide gene as effectively as the alpha-fetoprotein promoter.
Tomizawa M; Yu L; Wada A; Tamaoki T; Kadomatsu K; Muramatsu T; Matsubara S; Watanabe K; Ebara M; Saisho H; Sakiyama S; Tagawa M
Br J Cancer; 2003 Sep; 89(6):1086-90. PubMed ID: 12966430
[TBL] [Abstract][Full Text] [Related]
14. A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel.
Ji X; Shen Y; Sun H; Gao X
Tumour Biol; 2016 Aug; 37(8):10085-96. PubMed ID: 26820129
[TBL] [Abstract][Full Text] [Related]
15. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
[TBL] [Abstract][Full Text] [Related]
16. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice.
Liu H; Xu HW; Zhang YZ; Huang Y; Han GQ; Liang TJ; Wei LL; Qin CY; Qin CK
World J Gastroenterol; 2015 Sep; 21(36):10367-74. PubMed ID: 26420963
[TBL] [Abstract][Full Text] [Related]
18. Noscapine inhibits human hepatocellular carcinoma growth through inducing apoptosis in vitro and in vivo.
Xu G; Niu Z; Dong J; Zhao Y; Zhang Y; Li X
Neoplasma; 2016; 63(5):726-33. PubMed ID: 27468876
[TBL] [Abstract][Full Text] [Related]
19. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
Hui F; Qin X; Zhang Q; Li R; Liu M; Ren T; Zhao M; Zhao Q
Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.
Takei Y; Kadomatsu K; Matsuo S; Itoh H; Nakazawa K; Kubota S; Muramatsu T
Cancer Res; 2001 Dec; 61(23):8486-91. PubMed ID: 11731432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
